Dr. Guan-Da Syu
Dr. Guan-Da Syu
Position: Associate Professor
Group: Biomedical technology
Research Interests: Protein Microarray, Host and Microbial Interactions, High Throughput Technology
E-mail: guanda@gs.ncku.edu.tw
Room: 89A07
Room Tel：+886-6-2757575#58231
Laboratory Tel：+886-6-2757575#58244#111
|
School |
Department |
Country |
Degree |
Period |
|---|---|---|---|---|
|
National Cheng Kung University |
Graduate Institute of Basic Medical Science |
Taiwan |
Ph.D. |
2005 ~ 2012 |
|
National Cheng Kung University |
Environmental Engineering, Minor in Life Science |
Taiwan |
B.S. |
2001 ~ 2005 |
|
Institution |
Position |
Period |
|---|---|---|
| Associate Professor, Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Taiwan | Associate Professor |
2023- present |
|
Assistant professor, Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Taiwan |
Assistant professor |
2019~2023 |
|
Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, USA |
Postdoc. |
2015- 2019 |
|
Graduate Institute of Systems Biology and Bioinformatics, National Central University, Taiwan |
Postdoc. |
2013-2015 |
|
Department of Physiology, National Cheng Kung University, Taiwan |
Postdoc. |
2012- 2013 |
Honors
|
Honors |
Year |
|
NCKU Outstanding Industry-Academia Collaboration Achievement Award Merit Award |
2026 |
| Fulbright Senior Scholar Research Grant | 2026 |
|
International Distinguished Inventor Academic Guo-guang Medal |
2025 |
| The 21st National Innovation Award-Clinical Innovation Award |
2024 |
| 113th National Colleges and Universities Precision Health Industry Innovation and Entrepreneurship Competition - Smart Health Cross-field Bronze Award |
2024 |
|
The 21st National Innovation Award- Excellence Advancement Award |
2024 |
| NCKU Distinguished Academic Research Grant |
2024 |
| The 20th National Innovation Award- Excellence Advancement Award |
2023 |
| Future Technology Award | 2023 |
| NCKU Distinguished Academic Research Grant |
2023 |
| The 19th National Innovation Award-Clinical Innovation Award |
2022 |
| Future Tech Award Exhibition |
2022 |
|
NCKU Distinguished Academic Research Grant |
2022 |
| The 18th National Innovation Award – Academic and Research Innovation Award |
2021 |
|
Taiwan Comprehensive University System Young Scholar Innovative Research Achievement Competition – Distinguished Award |
2021 |
| Project for Excellent Junior Research Investigators, Ministry of Science and Technology | 2021-2025 |
|
Taiwan Comprehensive University System Young Scholar Innovative Research Achievement Competition – Honorable Mention Award |
2020 |
| Ministry of Science and Technology Postdoctoral Research Abroad Program | 2016-2017 |
Research Interests
Our laboratory mainly uses high-throughput methods to discuss the direction of vaccine protection against diseases, the cause of infection, drug screening, etc., and uses viral envelope to purify membrane proteins to explore major pathogenic biomarkers.
 |
SARS-CoV-2 Now that mutant strains are raging around the world, it is not known whether vaccines can protect against multiple mutant strains. The team developed the world's only high-throughput Coronavirus variant (CoVariant) protein array to evaluate the response after vaccination. |
 |
G protein-coupled receptors (GPCRs) It is a very important membrane protein in information transmission and drug development. Due to the difficulty in protein expression and functional research due to the structure of seven transmembrane structures, developed a virus expression method-embedding GPCRs in the viral envelope, in addition to maintaining the configuration And functions, simpler purification and production of protein chips, GPCR chips can be used to detect the specificity of antibody drugs, ligand specificity, search for infection receptors and drug development, etc. |
.svg.png)
